Preferences for different treatment options among people living with acromegaly in the US

References

• Zahr R, Fleseriu M. Updates in diagnosis and treatment of acromegaly. Eur Endocrinol. 2018;14(2):57–61. doi:10.17925/EE.2018.14.2.57.
   PubMedGoogle Scholar
• Lavrentaki A, Paluzzi A, Wass JAH, et al. Epidemiology of acromegaly: review of population studies. Pituitary. 2017;20(1):4–9. doi:10.1007/s11102-016-0754-x.
   PubMed Web of Science ®Google Scholar
• Whittington MD, Munoz KA, Whalen JD, et al. Economic and clinical burden of comorbidities among patients with acromegaly. Growth Horm IGF Res. 2021;59:101389. doi:10.1016/j.ghir.2021.101389.
   PubMed Web of Science ®Google Scholar
• Fleseriu M, Biller BMK, Freda PU, et al. A pituitary society update to acromegaly management guidelines. Pituitary. 2021;24(1):1–13. doi:10.1007/s11102-020-01091-7.
   PubMed Web of Science ®Google Scholar
• Fleseriu M, Molitch M, Dreval A, et al. Disease and treatment-related burden in patients With acromegaly who are biochemically controlled on injectable somatostatin receptor ligands. Front Endocrinol (Lausanne). 2021;12:627711. doi:10.3389/fendo.2021.627711.
   PubMed Web of Science ®Google Scholar
• Strasburger CJ, Karavitaki N, Störmann S, et al. Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly. Eur J Endocrinol. 2016;174(3):355–362. doi:10.1530/EJE-15-1042.
   PubMed Web of Science ®Google Scholar
• Colao A, Grasso LFS, Giustina A, et al. Acromegaly. Nat Rev Dis Primer. 2019;5:20.
   PubMed Web of Science ®Google Scholar
• Geer EB, Sisco J, Adelman DT, et al. Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice. BMC Endocr Disord. 2020;20(1):117. doi:10.1186/s12902-020-00595-4.
   PubMed Web of Science ®Google Scholar
• Giustina A, Barkan A, Beckers A, et al. A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab. 2020;105(4):e937–46–e946. doi:10.1210/clinem/dgz096.
   Web of Science ®Google Scholar
• Carmichael JD, Broder MS, Cherepanov D, et al. The association between biochemical control and cardiovascular risk factors in acromegaly. BMC Endocr Disord. 2017;17(1):15. doi:10.1186/s12902-017-0166-6.
   PubMed Web of Science ®Google Scholar
• Maffezzoni F, Formenti AM, Mazziotti G, et al. Current and future medical treatments for patients with acromegaly. Expert Opin Pharmacother. 2016;17(12):1631–1642. doi:10.1080/14656566.2016.1199687.
   PubMed Web of Science ®Google Scholar
• Ershadinia N, Tritos NA. Diagnosis and treatment of acromegaly: an update. Mayo Clin Proc. 2022;97(2):333–346. doi:10.1016/j.mayocp.2021.11.007.
   PubMed Web of Science ®Google Scholar
• Coopmans EC, Andela CD, Claessen KMJA, et al. Evaluating the impact of acromegaly on quality of life. Endocrinol Metab Clin North Am. 2022;51(4):709–725. doi:10.1016/j.ecl.2022.04.004.
   PubMed Web of Science ®Google Scholar
• Liu S, Adelman DT, Xu Y, et al. Patient-Centered assessment on disease burden, quality of life, and treatment satisfaction associated with acromegaly. J Investig Med. 2018;66(3):653–660. doi:10.1136/jim-2017-000570.
   PubMed Web of Science ®Google Scholar
• Webb SM, Badia X. Quality of life in acromegaly. Neuroendocrinology. 2016;103(1):106–111. doi:10.1159/000375451.
   PubMed Web of Science ®Google Scholar
• Ribeiro-Oliveira A, Brook RA, Munoz KA, et al. Burden of acromegaly in the United States: increased health services utilization, location of care, and costs of care. J Med Econ. 2021;24(1):432–439. doi:10.1080/13696998.2021.1898968.
   PubMed Web of Science ®Google Scholar
• Christofides E. Clinical importance of achieving biochemical control with medical therapy in adult patients with acromegaly. Patient Prefer Adherence. 2016;10:1217–1225. doi:10.2147/PPA.S102302.
   PubMed Web of Science ®Google Scholar
• Melmed S, Bronstein MD, Chanson P, et al. A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol. 2018;14(9):552–561. doi:10.1038/s41574-018-0058-5.
   PubMed Web of Science ®Google Scholar
• Katznelson L, Laws ER, Melmed S, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933–3951. doi:10.1210/jc.2014-2700.
   PubMed Web of Science ®Google Scholar
• Gadelha MR, Wildemberg LE, Kasuki L. The future of somatostatin receptor ligands in acromegaly. J Clin Endocrinol Metab. 2022;107(2):297–308. doi:10.1210/clinem/dgab726.
   PubMed Web of Science ®Google Scholar
• Maia B, Kasuki L, Gadelha MR. Novel therapies for acromegaly. Endocr Connect. 2020;9(12):R274–R285. doi:10.1530/EC-20-0433.
   PubMed Web of Science ®Google Scholar
• Kamusheva M, Vandeva S, Mitov K, et al. Adherence to acromegaly treatment and analysis of the related factors—a real-world study in Bulgaria. Pharmaceutics. 2023;15(2):438. doi:10.3390/pharmaceutics15020438.
   PubMed Web of Science ®Google Scholar
• Störmann S, Cuny T. The socioeconomic burden of acromegaly. Eur J Endocrinol. 2023;189(2):R1–R10. doi:10.1093/ejendo/lvad097.
   PubMed Web of Science ®Google Scholar
• Brod M, Højbjerre L, Alolga SL, et al. Understanding treatment burden for children treated for growth hormone deficiency. Patient. 2017;10(5):653–666. doi:10.1007/s40271-017-0237-9.
   PubMedGoogle Scholar
• Boguszewski CL, Korbonits M, Artignan A, et al. Evaluating home injection compared with healthcare-setting injection of somatostatin analogs: a systematic literature review. Endocrine. 2022;79(3):527–536. doi:10.1007/s12020-022-03227-0.
   PubMed Web of Science ®Google Scholar
• Saenger P, Federman AD, DeCherrie LV, et al. Choosing inpatient vs home treatment: why patients accept or decline hospital at home. J Am Geriatr Soc. 2020;68(7):1579–1583. doi:10.1111/jgs.16486.
   PubMed Web of Science ®Google Scholar
• Kremidas D, Wisniewski T, Divino VM, et al. Administration burden associated With recombinant human growth hormone treatment: perspectives of patients and caregivers. J Pediatr Nurs. 2013;28(1):55–63. doi:10.1016/j.pedn.2011.12.006.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Sato T, Yuasa A, et al. Patient preferences for growth hormone treatment in japanese children. Pediatr Int. 2021;63(10):1185–1191. doi:10.1111/ped.14760.
   PubMed Web of Science ®Google Scholar
• Miller BS, Blair JC, Rasmussen MH, et al. Weekly somapacitan is effective and well tolerated in children With GH deficiency: the randomized phase 3 REAL4 trial. J Clin Endocrinol Metab. 2022;107(12):3378–3388. doi:10.1210/clinem/dgac513.
   PubMed Web of Science ®Google Scholar
• Kappelgaard A-M, Metzinger CP, Schnabel D. A web-based survey assessing the impact of storage flexibility on the daily life of patients and caregivers administering growth hormone. Expert Rev Med Devices. 2015;12(5):517–527. doi:10.1586/17434440.2015.1069180.
   PubMed Web of Science ®Google Scholar
• Rice S, Winter SR, Doherty S, et al. Advantages and disadvantages of using internet-based survey methods in aviation-related research. J Aviat Technol Eng. 2017;7(1):58–65. Available from: https://docs.lib.purdue.edu/jate/vol7/iss1/5
   Google Scholar
• Lenders NF, McCormack AI, Ho KKY. MANAGEMENT OF ENDOCRINE DISEASE: does gender matter in the management of acromegaly? Eur J Endocrinol. 2020;182(5):R67–R82. doi:10.1530/EJE-19-1023.
   PubMed Web of Science ®Google Scholar
• Davis RE, Jacklin R, Sevdalis N, et al. Patient involvement in patient safety: what factors influence patient participation and engagement? Health Expect. 2007;10(3):259–267. doi:10.1111/j.1369-7625.2007.00450.x.
   PubMed Web of Science ®Google Scholar
• Thompson AE, Anisimowicz Y, Miedema B, et al. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016;17(1):38. doi:10.1186/s12875-016-0440-0.
   PubMed Web of Science ®Google Scholar
• Longtin Y, Sax H, Leape LL, et al. Patient participation: current knowledge and applicability to patient safety. Mayo Clin Proc. 2010;85(1):53–62. doi:10.4065/mcp.2009.0248.
   PubMed Web of Science ®Google Scholar